CPHI Stock Analysis: Buy, Sell, or Hold?
CPHI - China Pharma Holdings, Inc.
$0.61
-0.01 (-1.63%)
▼
5d:
-7.2%
30d:
-19.83%
90d:
-5.39%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
28d
Get Alerted When CPHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CPHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CPHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CPHI is currently trading at $0.61, which is considered oversold relative to its 30-day fair value range of $0.63 to $0.77.
Technical Outlook: Technically, CPHI is showing sideways momentum. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CPHI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.00 (+388.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CPHI is showing sideways momentum. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CPHI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.00 (+388.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.63 -
$0.77
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 388.0% below Wall St target ($3.00)
- CAUTION: 5-day price weakness (-7.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.63 -
$0.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.90
Current Trend
Sideways
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.56
Wall Street Target
$3.00
(+388.0%)
Revenue Growth (YoY)
-13.4%
Profit Margin
-88.8%
Share & Embed Analysis
Last updated: July 15, 2026 4:38 AM ET
Data refreshes hourly during market hours. Next update: 5:38 AM
Data refreshes hourly during market hours. Next update: 5:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPHI showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 54 HOLD |
